COVID-19 'rebound' reported after taking antiviral pill; CDC says drug still beneficial

As new COVID-19 cases rise, Paxlovid is being prescribed to try to keep high-risk patients out of the hospital. But the Centers for Disease Control and Prevention is warning of a potential "COVID-19 rebound" after a five-day course of the treatment.